Painful Diabetic Peripheral Neuropathy: Results of a Survey Characterizing the Perspectives and Misperceptions of Patients and Healthcare Practitioners
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Little information exists on the understanding and management of painful diabetic peripheral neuropathy (pDPN) between patients and healthcare practitioners (HCPs). OBJECTIVE: The objective of this study was to characterize the patient perspective of pDPN and identify gaps in patient and HCP perceptions of pDPN. METHODS: An online survey of patients with type 1 or 2 diabetes mellitus who reported experiencing any symptoms consistent with diabetic peripheral neuropathy (DPN) and HCPs who treat diabetes was conducted in 2012 in the USA. Patients were recruited via the Survey Sampling national consumer research panel, and HCPs were recruited from Epocrates' national research panel. Survey questions focused on the impact, understanding, and management of pDPN, and interactions between patients and their HCPs. Respondents who reported pain were re-contacted to obtain further information on pain severity using a numerical rating scale (0 = no pain, 10 = most pain). RESULTS: Respondents included 1,004 patients (53 % female, average age 55 years) and 500 HCPs (250 generalists, 150 specialists, and 100 nurses/physician assistants). While 83 % of patients reported pDPN symptoms, only 41 % of these patients had been diagnosed with DPN. Eighty-five percent of those with pDPN reported that it impacts daily activities. In contrast, HCPs estimated that of their patients who experienced any type of DPN symptom, 41 % experienced pain and 38 % had daily activity limitations because of their symptoms. Most HCPs (64 %) never had their patients complete a DPN assessment questionnaire, and only 41 % perform specific diagnostic tests on all patients who report DPN symptoms. Patients and HCPs both showed substantial clinical misperceptions regarding the cause and management of pDPN; 53 % of HCPs believed that adequate blood glucose control could reverse DPN, and 43 % of pDPN patients were not sure if DPN was reversible. There was also substantial discordance between patients and HCPs regarding discussions of DPN; only 49 % of pDPN patients reported that they speak about symptoms at "every" or "most" appointments with their HCP but 73 % of HCPs reported discussing DPN symptoms at "every" or "most" visits. CONCLUSIONS: Not only do misperceptions exist on the cause and management of pDPN among patients and HCPs, but there are additional disparities between the patient and HCP perspectives. These results suggests a need for (1) educational initiatives on pDPN that target patients and HCPs, and (2) initiating improved dialogue between patients and their HCPs for discussing appropriate management of pDPN that is distinct from treatment of the underlying diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neuropathic pain may be the first symptom that prompts persons to seek medical care and is present in up to 25% to 30% of individuals with DPN.547,555–559”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [559]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Neuropathic pain may be the first symptom that prompts persons to seek medical care and is present in up to 25% to 30% of individuals with DPN.547,555–559”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [559]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
Galer, B. S., Gianas, A., & Jensen, M. P. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00112-6 · Cited by 601
Gore, M., Brandenburg, N. A., Dukes, E., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.04.009 · Cited by 525
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Van Acker, K., Bouhassira, D., De Bacquer, D., Weiss, S., Matthys, K., Raemen, H., Mathieu, C., & Colin, I. M. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.11.004 · Cited by 408
Diabetic peripheral neuropathy and quality of life
Benbow, S. (1998) · QJM · doi:10.1093/qjmed/91.11.733 · Cited by 262
Burden of Illness in Painful Diabetic Peripheral Neuropathy: The Patients’ Perspectives
Gore, M., Brandenburg, N. A., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2006.04.013 · Cited by 239
Zelman, D. C., Dukes, E., Brandenburg, N., Bostrom, A., & Gore, M. (2005) · Pain · doi:10.1016/j.pain.2005.01.028 · Cited by 236
Tölle, T., Xu, X., & Sadosky, A. B. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.09.007 · Cited by 199
Self-citation
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The global and regional burden of diabetic peripheral neuropathy
Savelieff, M. G., Elafros, M. A., Viswanathan, V., Jensen, T. S., Bennett, D., & Feldman, E. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01041-y · Cited by 195
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
“[26] also reported significant clinical misperceptions by healthcare professionals in the perceived prevalence of pDPN compared to actual estimates reported by patients.”
ResultMalik, R. A., Aldinc, E., Chan, S.-P., Deerochanawong, C., Hwu, C., Rosales, R. L., Yeung, C., Fujii, K., & Parsons, B. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0536-5 · Cited by 62
Self-citationPrevalence and risk factors of painful diabetic neuropathy: A systematic review and meta-analysis
Tao, Y. K., Zhang, H. Y., MacGilchrist, C., Kirwan, E., & McIntosh, C. D. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112099 · Cited by 76
Metadata
- Authors
- Sadosky, A., Hopper, J., & Parsons, B.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Sadosky, Alesia
- ORCID
- Parsons, Bruce
- Venue
- The Patient - Patient-Centered Outcomes Research
- Published
- 2013-11-22
- Volume
- 7
- Issue
- 1
- Pages
- 107-114
- ISSN
- 1178-1653 (ISSN-L)
- 1178-1661
- PMC
- PMC3929775
- OpenAlex
- W2003504000
- Cited by
- 42
- References
- 22
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 3
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Patient (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- diabetic neuropathic pain, diabetic peripheral neuropathy, patient perspectives, patient-physician communication, neuropathy diagnosis, neuropathy assessment, neuropathic pain, glycemic control, type 1 diabetes, type 2 diabetes, pain intensity, daily activity limitations, diabetes management education, patient education materials
- MeSH terms
- Diabetes Mellitus, Diabetic Neuropathies, Female, Humans, Male, Middle Aged, Patients, Perception, Physicians, Quality of Life, Internet, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Painful Diabetic Peripheral Neuropathy: Results of a Survey Characterizing the Perspectives and Misperceptions of Patients and Healthcare Practitioners. https://app.cochat.ai/papers/10.1007/s40271-013-0038-8
- The paper
- Sadosky, A., Hopper, J., & Parsons, B. (2014). Painful Diabetic Peripheral Neuropathy: Results of a Survey Characterizing the Perspectives and Misperceptions of Patients and Healthcare Practitioners. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-013-0038-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.